Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Author affiliation: National Center for Cardiovascular…

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Author affiliation: National Center for Cardiovascular…

Newborns of mothers vaccinated against pertussis (whooping cough) during pregnancy have antibodies not only in their blood but also in their nasal membranes, the entry site for Bordetella pertussis, the bacteria that cause the highly contagious…

— New guidance and financial modeling tool support organizations transitioning to value-based care —
CHICAGO, Jan. 15, 2026 /PRNewswire/ — The Alzheimer’s Association Dementia…

Magtein has received new clinical backing for its effects in boosting cognitive performance, memory, reaction time, brain cognitive age, and heart rate variability. This patented proprietary form of magnesium L-threonate has been extensively…

The global prevalence of obesity has tripled since 1975, and the economic burden of obesity and overweight is projected to reach 3.3% of global gross domestic product by 2060 []. Beyond economic considerations, obesity…

A research team from the University of Liverpool has reported new evidence suggesting that sharp increases in blood sugar following meals may raise the risk of Alzheimer’s disease. The findings point to after-meal glucose levels as a potential…

Baseline fatigue reported before cancer treatment is strongly associated with a higher risk of severe and fatal treatment related toxic effects, according to a large, pooled analysis of randomised clinical trial data.

Baseline fatigue reported before cancer treatment is strongly associated with a higher risk of severe and fatal treatment related toxic effects, according to a large, pooled analysis of randomised clinical trial data.

A male patient, aged 28, with B-cell acute lymphoblastic leukemia (B-cell ALL) was treated with obe-cel, a CAR-T therapy, on the UK’s NHS England – the first leukemia patient to receive this CAR-T on the NHS.
For several years,…